James Haltom, MD
Allergy & Immunology · Jackson, MSNPI 1710965694
Payments from drug & device makers
Across 564 payments — averaging $19.11 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AstraZeneca$2K
- GSK$2K
- CSL Behring$2K
- Regeneron Healthcare Solutions, Inc.$1K
- Genentech USA, Inc.$906
- Novartis$664
- plus $3K from 25 others
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AstraZeneca | 72 | $1,665 |
| GSK | 115 | $1,542 |
| CSL Behring | 58 | $1,536 |
| Regeneron Healthcare Solutions, Inc. | 51 | $1,123 |
| Genentech USA, Inc. | 46 | $906 |
| Novartis | 37 | $664 |
| Takeda Pharmaceuticals U.S.A., Inc. | 29 | $570 |
| Pfizer | 30 | $515 |
| Grifols USA, LLC | 22 | $378 |
| Amgen | 17 | $293 |
| Octapharma USA, Inc. | 11 | $246 |
| Sanofi | 5 | $220 |
| Boehringer Ingelheim | 14 | $192 |
| Pharming Healthcare, Inc. | 8 | $140 |
| Kaleo, Inc. | 10 | $140 |
| Shire North American Group Inc | 6 | $107 |
| AbbVie | 6 | $99 |
| Merck | 4 | $77 |
| Teva Pharmaceuticals USA, Inc. | 6 | $75 |
| Blueprint Medicines Corporation | 2 | $54 |
| QOL Medical, LLC | 2 | $39 |
| Optinose US, Inc. | 2 | $37 |
| LEO Pharma Inc. | 2 | $32 |
| Biocryst Pharmaceuticals, Inc. | 2 | $25 |
| Greer Laboratories, Inc. | 1 | $23 |
| Philips North America LLC | 1 | $15 |
| Lilly USA, LLC | 1 | $14 |
| Phathom Pharmaceuticals, Inc. | 1 | $14 |
| Biocryst US Sales Co., LLC | 1 | $13 |
| Incyte Corporation | 1 | $13 |
| Cycle Pharmaceuticals Inc | 1 | $12 |
How this compares
$10,779 in reported general payments places this provider in the 50th percentile of 28 allergy & immunology providers in Mississippi.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Other allergy & immunology in Jackson
- Gailen MarshallJackson$266K
- Todd AdkinsJackson$226K
- Daniel VenarskeJackson$156K
- Dexter WalcottJackson$154K
- Chelle WilhelmJackson$61K
- Joshua PhillipsJackson$20K
- Claire RosenblattJackson$11K
- Sheryll VincentJackson$3K
- Matthew ElliottJackson$862
- Stephen KempJackson$68
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.